FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2750145485> ?p ?o ?g. }

• W2750145485 endingPage "697" @default.
• W2750145485 startingPage "674" @default.
• W2750145485 abstract "Recently, more and more concomitant EGFR mutations and ALK rearrangement are observed from the clinic, which still lacks effective single-agent therapy. Starting from ALK inhibitor 14 (TAE684), we have developed a highly potent EGFR/ALK dual kinase inhibitor compound 18 (CHMFL-ALK/EGFR-050), which potently inhibited EGFR L858R, del 19 and T790M mutants as well as EML4-ALK, R1275Q, L1196M, F1174L and C1156Y mutants biochemically. Compound 18 significantly inhibited the proliferation of EGFR mutant and EML4-ALK driven NSCLC cell lines. In the cellular context it strongly affected EGFR and ALK mediated signaling pathways, induced apoptosis and arrested cell cycle at G0/G1 phase. In the in vivo studies, 18 significantly suppressed the tumor growth in H1975 cell inoculated xenograft model (40 mg/kg/d, TGI: 99%) and H3122 cell inoculated xenograft model (40 mg/kg/d, TGI: 78%). Compound 18 might be a potential drug candidate for EGFR- or ALK-individual as well as concomitant EGFR/ALK NSCLC." @default.
• W2750145485 created "2017-08-31" @default.
• W2750145485 creator A5000728648 @default.
• W2750145485 creator A5012278873 @default.
• W2750145485 creator A5013338637 @default.
• W2750145485 creator A5014255862 @default.
• W2750145485 creator A5017242815 @default.
• W2750145485 creator A5018594201 @default.
• W2750145485 creator A5029503387 @default.
• W2750145485 creator A5035282947 @default.
• W2750145485 creator A5046597133 @default.
• W2750145485 creator A5052437697 @default.
• W2750145485 creator A5054794579 @default.
• W2750145485 creator A5056391726 @default.
• W2750145485 creator A5058132534 @default.
• W2750145485 creator A5058484759 @default.
• W2750145485 creator A5062755510 @default.
• W2750145485 creator A5070433780 @default.
• W2750145485 creator A5071417968 @default.
• W2750145485 creator A5076875138 @default.
• W2750145485 date "2017-10-01" @default.
• W2750145485 modified "2023-10-16" @default.
• W2750145485 title "Discovery of N -(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC" @default.
• W2750145485 cites W1972666742 @default.
• W2750145485 cites W1972760716 @default.
• W2750145485 cites W1988750150 @default.
• W2750145485 cites W1995770177 @default.
• W2750145485 cites W1996244557 @default.
• W2750145485 cites W2003892109 @default.
• W2750145485 cites W2005668490 @default.
• W2750145485 cites W2007528734 @default.
• W2750145485 cites W2014639631 @default.
• W2750145485 cites W2031494655 @default.
• W2750145485 cites W2035495099 @default.
• W2750145485 cites W2040575339 @default.
• W2750145485 cites W2043696829 @default.
• W2750145485 cites W2055402151 @default.
• W2750145485 cites W2066417528 @default.
• W2750145485 cites W2070971017 @default.
• W2750145485 cites W2080992857 @default.
• W2750145485 cites W2081801534 @default.
• W2750145485 cites W2088540000 @default.
• W2750145485 cites W2090029719 @default.
• W2750145485 cites W2110841878 @default.
• W2750145485 cites W2111254482 @default.
• W2750145485 cites W2133963438 @default.
• W2750145485 cites W2135381701 @default.
• W2750145485 cites W2139236349 @default.
• W2750145485 cites W2140333474 @default.
• W2750145485 cites W2140363584 @default.
• W2750145485 cites W2146418087 @default.
• W2750145485 cites W2152905269 @default.
• W2750145485 cites W2161821474 @default.
• W2750145485 cites W2293504667 @default.
• W2750145485 cites W2330799739 @default.
• W2750145485 cites W2339922740 @default.
• W2750145485 cites W2533300620 @default.
• W2750145485 cites W2611868247 @default.
• W2750145485 doi "https://doi.org/10.1016/j.ejmech.2017.08.035" @default.
• W2750145485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28850922" @default.
• W2750145485 hasPublicationYear "2017" @default.
• W2750145485 type Work @default.
• W2750145485 sameAs 2750145485 @default.
• W2750145485 citedByCount "35" @default.
• W2750145485 countsByYear W27501454852018 @default.
• W2750145485 countsByYear W27501454852019 @default.
• W2750145485 countsByYear W27501454852020 @default.
• W2750145485 countsByYear W27501454852021 @default.
• W2750145485 countsByYear W27501454852022 @default.
• W2750145485 countsByYear W27501454852023 @default.
• W2750145485 crossrefType "journal-article" @default.
• W2750145485 hasAuthorship W2750145485A5000728648 @default.
• W2750145485 hasAuthorship W2750145485A5012278873 @default.
• W2750145485 hasAuthorship W2750145485A5013338637 @default.
• W2750145485 hasAuthorship W2750145485A5014255862 @default.
• W2750145485 hasAuthorship W2750145485A5017242815 @default.
• W2750145485 hasAuthorship W2750145485A5018594201 @default.
• W2750145485 hasAuthorship W2750145485A5029503387 @default.
• W2750145485 hasAuthorship W2750145485A5035282947 @default.
• W2750145485 hasAuthorship W2750145485A5046597133 @default.
• W2750145485 hasAuthorship W2750145485A5052437697 @default.
• W2750145485 hasAuthorship W2750145485A5054794579 @default.
• W2750145485 hasAuthorship W2750145485A5056391726 @default.
• W2750145485 hasAuthorship W2750145485A5058132534 @default.
• W2750145485 hasAuthorship W2750145485A5058484759 @default.
• W2750145485 hasAuthorship W2750145485A5062755510 @default.
• W2750145485 hasAuthorship W2750145485A5070433780 @default.
• W2750145485 hasAuthorship W2750145485A5071417968 @default.
• W2750145485 hasAuthorship W2750145485A5076875138 @default.
• W2750145485 hasConcept C126322002 @default.
• W2750145485 hasConcept C150903083 @default.
• W2750145485 hasConcept C151730666 @default.
• W2750145485 hasConcept C170493617 @default.
• W2750145485 hasConcept C184235292 @default.
• W2750145485 hasConcept C185592680 @default.
• W2750145485 hasConcept C190283241 @default.
• W2750145485 hasConcept C207001950 @default.
• W2750145485 hasConcept C2777506169 @default.

• next